Recursion Pharmaceuticals (RXRX) Total Debt (2020 - 2026)
Recursion Pharmaceuticals' Total Debt was $14.2 million in Q2 2026, down 38.1% from $22.95 million a year earlier and down 13.7% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Total Debt (2020 - 2026) Analysis & Trends
At the end of FY2025, Total Debt at Recursion Pharmaceuticals came in at $18.66 million, down 32.0% from FY2024.
- Total Debt shows a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- In earlier years, Total Debt was $27.45 million in FY2024, $1.18 million in FY2023 (+86.9%), $633,000 in FY2022 (-12.4%) and $723,000 in FY2021 (-94.2%).
- The Q2 2026 figure marks the lowest quarterly Total Debt since Q1 2024.
- Compared with a year earlier, Total Debt has declined for five straight quarters, with an average decline of 31.6% over the last five quarters.
- The best year-over-year quarter for Total Debt over five years was Q3 2023 (growth of 177.6%); the worst was Q2 2022 (a decline of 94.6%).
- Per Business Quant data, RXRX's Total Debt in the three quarters before Q2 2026 was $16.45 million (Q1 2026), $18.66 million (Q4 2025) and $20.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | 14.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.20 Mn |
| Mar 31, 2026 | 16.45 Mn |
| Dec 31, 2025 | 18.66 Mn |
| Sep 30, 2025 | 20.82 Mn |
| Jun 30, 2025 | 22.95 Mn |
| Mar 31, 2025 | 25.03 Mn |
| Dec 31, 2024 | 27.45 Mn |
| Sep 30, 2024 | 28.73 Mn |
| Jun 30, 2024 | 31.03 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 633,000.00 |
| Sep 30, 2022 | 656,000.00 |
| Jun 30, 2022 | 679,000.00 |
| Mar 31, 2022 | 702,000.00 |
| Dec 31, 2021 | 723,000.00 |
| Sep 30, 2021 | 744,000.00 |
API Access
Recursion Pharmaceuticals Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();